Patient and Provider Resources
SMRI primarily funds research into the causes and treatments of schizophrenia and bipolar disorders but does not provide direct patient care. The following resources and links may be of use to providers, patients and families in identifying additional organizations committed to schizophrenia and bipolar research and outreach.
Repurposed Drug Database
An article on selected repurposed drugs was published in Clinical Schizophrenia and Related Psychoses in January 2012 by Drs. E. Fuller Torrey and John M. Davis. The drugs listed are those for which treatment trials have been supported by SMRI. This information will be updated as new data on these drugs becomes available.
Our Toxoplasmosis–Schizophrenia Research section is maintained by the Stanley Medical Research Institute (SMRI) and the Stanley Division of Developmental Neurovirology for researchers and others interested in the possible etiological relationship between Toxoplasma gondii (and related organisms) and schizophrenia (and related psychoses).